Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for AAGH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
March 31, 2026 -4.798M
December 31, 2025 -4.632M
September 30, 2025 -5.746M
June 30, 2025 -5.661M
March 31, 2025 -5.627M
December 31, 2024 -5.494M
September 30, 2024 -5.307M
June 30, 2024 -5.231M
March 31, 2024 -4.796M
December 31, 2023 -4.702M
September 30, 2023 -4.605M
June 30, 2023 -4.451M
March 31, 2023 -4.283M
December 31, 2022 -4.088M
September 30, 2022 -3.964M
June 30, 2022
March 31, 2022 -3.102M
December 31, 2021 -2.595M
September 30, 2021 -0.7963M
June 30, 2021 -0.4678M
March 31, 2021 -0.2966M
December 31, 2020 -0.2508M
September 30, 2020 -0.2162M
June 30, 2020 -0.215M
March 31, 2020 -0.1825M
Date Value
December 31, 2019 -0.181M
September 30, 2019 -0.171M
June 30, 2019 -0.168M
March 31, 2019 -0.1592M
December 31, 2018 -0.1516M
September 30, 2018 -0.1151M
June 30, 2018 -0.1075M
March 31, 2018 -0.0859M
December 31, 2017 -0.0768M
September 30, 2017 -0.0618M
June 30, 2017 -0.0481M
March 31, 2017 -0.0118M
December 31, 2016 -0.7058M
September 30, 2016 -0.5151M
June 30, 2016 -1.093M
March 31, 2016 -1.021M
December 31, 2015 -0.7477M
September 30, 2015 -0.6624M
June 30, 2015 -0.9978M
March 31, 2015 -0.8305M
December 31, 2014 -0.6717M
September 30, 2014 -0.5121M
June 30, 2014 -0.3533M
March 31, 2014 -0.2016M
December 31, 2013 -0.0499M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
AbbVie, Inc. -5.935B
Abeona Therapeutics, Inc. 128.06M
Acumen Pharmaceuticals, Inc. 57.26M
Abpro Holdings, Inc. -3.533M
Aardvark Therapeutics, Inc. 74.80M

Shareholders Equity (Quarterly) Related Metrics